Clinical Trials Directory

A Phase II Placebo-Controlled Trial of Modafinil to Improve Neurocognitive Deficits in Children Treated for a Primary Brain Tumor

The purpose of this trial is to study how well modafinil works in treating children with memory and attention problems caused by cancer treatment for a brain tumor. Modafinil may help improve memory, attention, and fatigue caused by cancer treatment.

Stanford is not currently accepting new patients for this trial. You may want to check to see if other locations are recruiting.



  • drug : modafinil
  • other : placebo

Phase: Phase 2


Ages Eligible For Study:

6 Years - 19 Years

External Links

Explore related trials

Contact information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Peds Hem/Onc CRAs
Not Recruiting

Footer Links: